Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Clopidogrel attenuates the complications associated with poor early reperfusion in patients with STEMI undergoing lysis in the CLARITY-IMI 28

Clopidogrel attenuates the complications associated with poor early reperfusion in patients with STEMI undergoing lysis in the CLARITY-IMI 28. J Am Coll Cardiol. 2006; (47:213A).


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.